Myelodysplastic Syndrome Clinical Trial

Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders

Summary

This study performs HLA matched stem cell transplantation from unrelated donors in adults who require stem cell transplantation but do not have a matched related donor available. The incidence of graft-versus-host disease in unrelated stem cell transplantation is recorded. This study also monitors the activity and toxicity of total body irradiation and cyclosphosphamide followed by stem cell transplantation from matched unrelated donors.

View Full Description

Full Description

This protocol identifies a standard-of-care method for unrelated stem cell transplantation in adults. Performing this service in a consistent and documented fashion allows investigators to obtain informed consent from recipients. Data is tabulated locally for quality-control comparisons with nationally-reported standards. As a condition of maintaining transplant center status and to have acess to NMDP-registered donors, UCSF submits clinical and outcome data to the NMDP. As a result, UCSF is contributing to the resolution of remaining uncertainties regarding particular transplantation practices.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age >15 and <55
Adequate renal function with serum creatinine <2.0 mg/dl
Pulmonary diffusing capacity>50% of predicted
Cardiac ejection fraction >40% as measured by radionuclide wall motion study or echocardiography
Total bilirubin must be <2.5 mg/dl.
Alkaline phosphatase and AST must be less than three times the upper limit of normal
Negative serology for the human immunodeficiency virus
Available HLA-matched donor
Signed informed consent

Exclusion Criteria:

No fully or single-antigen-mismatched sibling donor is available to donate stem cells
No active liver disease.

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

30

Study ID:

NCT00511537

Recruitment Status:

Completed

Sponsor:

University of California, San Francisco

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California San Francisco
San Francisco California, 94143, United States

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

30

Study ID:

NCT00511537

Recruitment Status:

Completed

Sponsor:


University of California, San Francisco

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider